Opyt primeneniya kapetsitabinau bol'nykh rakom molochnoy zhelezy s metastazami v golovnoy mozg
- Authors: Naskhletashvili DR1, Chmutin GE1, Karakhan VB1, Aleshin VA1, Fu RG1, Belov DM1, Ivanova EA1
-
Affiliations:
- ГУ РОНЦ им. Н.Н.Блохина РАМН., Москва
- Issue: Vol 11, No 1 (2009)
- Pages: 50-54
- Section: Articles
- URL: https://journals.rcsi.science/1815-1434/article/view/26759
- ID: 26759
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
D R Naskhletashvili
ГУ РОНЦ им. Н.Н.Блохина РАМН., Москва
G E Chmutin
ГУ РОНЦ им. Н.Н.Блохина РАМН., Москва
V B Karakhan
ГУ РОНЦ им. Н.Н.Блохина РАМН., Москва
V A Aleshin
ГУ РОНЦ им. Н.Н.Блохина РАМН., Москва
R G Fu
ГУ РОНЦ им. Н.Н.Блохина РАМН., Москва
D M Belov
ГУ РОНЦ им. Н.Н.Блохина РАМН., Москва
E A Ivanova
ГУ РОНЦ им. Н.Н.Блохина РАМН., Москва
References
- Chang E, Lob S. Diagnosis and Management of Central Nervous System Metastases from Breast Cancer. The Oncologist 2003; 8 (5): 398–410.
- Bendell J.C., Domchek S.M., Burstein H.J. et al. Central nervous system metastases in women who receive trastuzumab - based therapy for metastatic breast carcinoma. Cancer 2003; 97: 2972–7.
- Burstein H.J., Lieberman G, Slamon D.J. et al. Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first - line trastuzumab - based therapy. Ann Oncol 2005; 16: 1772–7.
- De la Monte S.M., Hutchins G.M., Moore G.W. Estrogen and progesterone receptors in prediction of metastatic behavior of breast carcinoma. Am J Med 1984; 76: 11–7.
- Heinrich B, Brudler O, Siekiera W et al. Development of brain metastasis in metastatic breast cancer responding to treatment with trastuzumab. Proc Am Soc Clin Oncol 2003 22: 37 (abstr 147).
- Lin N.U., Bellon J.R., Winer E.P. CNS metastases in breast cancer. J Clin Oncol 2004; 22: 3608–17.
- Samaan N.A., Buzdar A.U., Aldinger K.A. et al. Estrogen receptor: A prognostic factor in breast cancer. Cancer 1981; 47: 554–60.
- Bezjak A, Adam J, Barton R et al. Symptom response after palliative radiotherapy for patients with brain metastases. Eur J Cancer 2002; 38: 487–96.
- Khuntia D, Brown P, Li J et al. Whole - brain radiotherapy in the management of brain metastasis. J Clin Oncol 2006; 24: 1295–304.
- Tsao M.N., Lloyd N, Wong R et al. Whole brain radiotherapy for the treatment of multiple brain metastases. Cochrane Database Syst Rev 2006; 3: CD003869.
- Rosner D, Flower A, Lane W. Chemotherapy induces regression of brain metastases in breast carcinoma patients: update study. Proc Am Soc Clin Oncol 1993; 12: 508a.
- Rosner D, Nemoto T, Lane W.W. Chemotherapy induces regression of brain metastases in breast carcinoma. Cancer 1986; 58: 832–9.
- Cocconi G, Lottici R, Bisagni G et al. Combination therapy with platinum and etoposide of brain metastases from breast carcinoma. Cancer Invest 1990; 8: 327–34.
- Franciosi V, Cocconi G, Michiara M et al. Front - line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a prospective study. Cancer 1999; 85: 1599–605.
- Oberhoff C, Kieback D.G., Wurstlein R et al. Topotecan chemotherapy in patients with breast cancer and brain metastases: Results of a pilot study. Onkologie 2001; 24: 256–60.
- Christodoulou C, Bafaloukos D, Linardou H et al. Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: A Hellenic Cooperative Oncology Group (HeCOG) phase II study. J Neurooncol 2005; 71: 61–5.
- Fabi A, Vidiri A, Ferretti G et al. Dramatic regression of multiple brain metastases from breast cancer with capecitabine: Another arrow at the bow? Cancer Invest 2006; 24: 466–8.
- Hikino H, Yamada T, Johbara K et al. Potential role of chemo - radiation with oral capecitabine in a breast cancer patient with central nervous system relapse. Breast 2006; 15: 97–9.
- Siegelmann-Danieli N, Stein M, Bar-Ziv J. Complete response of brain metastases originating in breast cancer to capecitabine therapy. Isr Med Assoc J 2003; 5: 833–4.
- Wang M.L., Yung W.K., Royce M.E. et al. Capecitabine for 5-fluorouracil - resistant brain metastases from breast cancer. Am J Clin Oncol 2001; 24: 421–4.